Simoni Amalie Helme, Ahlstrøm Lina Marie Vinge, Ording Anne Gulbech, Iversen Lene Hjerrild, Johnsen Søren Paaske, Jensen Jens Winther, Møller Henrik
Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
The Danish Clinical Quality Program and Clinical Registries (RKKP), Aarhus, Denmark.
BMJ Open Qual. 2025 Jan 4;14(1):e003019. doi: 10.1136/bmjoq-2024-003019.
The Danish clinical quality registries monitor and improve the quality of care, using quality indicators and defined development targets referred to as 'standards'. This study aims to investigate the fulfilment of standards in the Danish clinical quality registries in cancer care and screening.
Data was included from annual reports in the 27 Danish clinical quality registries in cancer care and screening. The most recent report from each registry was downloaded the 13 December 2023. Indicators were included if: evaluating care or screening over 12 months, presenting a well-defined standard with a desired direction and presenting the proportion and number of individuals for which the standard was fulfilled. Data were extracted on national and regional levels for the last 3 years, and fulfilment of standards was presented as the proportion of indicators that fulfilled the standard within each unit of comparison.
In total, 216 quality indicators were included. At the national and regional level, standards were fulfilled for 75% and 71%, respectively. Fulfilment within the registries varied from 5% to 100% on national and 12% to 99% on regional level. Standards were more often fulfilled for result (than process indicators) and for established (than supplemental indicators). Altogether, 43% of the standards were fulfilled across all regions delivering data for the specific indicator.
The approach to defining standards for clinical quality indicators as conservative minimum or ambitious development targets varied in the Danish clinical quality registries in cancer care and screening. This deviating behaviour seriously restrains possibilities for comparing clinical quality across cancers despite the robust infrastructure of the quality registries, limiting the possibilities for overview and prioritising resources and attention to the most urgent cancers.
丹麦临床质量登记处通过质量指标和被称为“标准”的既定发展目标来监测和提高医疗质量。本研究旨在调查丹麦癌症护理和筛查临床质量登记处的标准达成情况。
纳入了丹麦27个癌症护理和筛查临床质量登记处的年度报告数据。每个登记处的最新报告于2023年12月13日下载。纳入指标的条件为:评估超过12个月的护理或筛查,呈现具有期望方向的明确标准,并呈现达到该标准的个体比例和数量。提取了过去3年国家和地区层面的数据,标准达成情况以每个比较单位内达到标准的指标比例呈现。
共纳入216项质量指标。在国家和地区层面,标准达成率分别为75%和71%。各登记处在国家层面的达成率从5%到100%不等,在地区层面从12%到99%不等。结果指标(相对于过程指标)和既定指标(相对于补充指标)更常达成标准。总体而言,在为特定指标提供数据的所有地区中,43%的标准得以达成。
在丹麦癌症护理和筛查临床质量登记处,将临床质量指标标准定义为保守的最低标准或雄心勃勃的发展目标的方法各不相同。尽管质量登记处有强大的基础设施,但这种偏差行为严重限制了跨癌症比较临床质量的可能性,限制了进行总体评估以及确定资源优先级和关注最紧迫癌症的可能性。